FIELD: pharmaceutical industry.
SUBSTANCE: invention relates to a compound which is 5-[(2,5-dimethylphenyl)methyl]-6-methyl-2-(1-methylpyrazol-4-yl)imidazo[2,1-b]-thiazole. Invention also relates to a pharmaceutical composition having the properties of a TNFα activity modulator, containing an effective amount of 5-[(2,5-dimethylphenyl)methyl]-6-methyl-2-(1-methylpyrazol-4-yl)imidazo[2,1-b]-thiazole with a pharmaceutically acceptable carrier.
EFFECT: disclosed compound is applicable for treating and/or preventing rheumatoid arthritis or Crohn's disease.
4 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
TRIAZOLOPYRIDAZINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2677698C1 |
BENZOTRIAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2677696C1 |
IMIDAZOPYRIMIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2691629C1 |
TETRAHYDROIMIDAZOPYRIDINE DERIVATIVES AS TNF ACTIVITY MODULATORS | 2014 |
|
RU2684635C1 |
PYRAZOLOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2684641C1 |
TRIAZOLOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2677697C1 |
TETRAHYDROIMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2696270C1 |
CONDENSED BICYCLIC HETEROAROMATIC DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2685234C1 |
IMIDAZOPYRIDAZINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2679609C1 |
IMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2678305C1 |
Authors
Dates
2019-04-03—Published
2014-12-08—Filed